Pet Inactivated Vaccine Market, Global Outlook and Forecast 2022-2028
Inactivated vaccines for pets are vaccines made from killed pathogens.
This report contains market size and forecasts of Pet Inactivated Vaccine in global, including the following market information:
Global Pet Inactivated Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pet Inactivated Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Pet Inactivated Vaccine companies in 2021 (%)
The global Pet Inactivated Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Obtained by Heat Killing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pet Inactivated Vaccine include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska, Merck Animal Health, Merial (Sanofi) and Virbac and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pet Inactivated Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pet Inactivated Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pet Inactivated Vaccine Market Segment Percentages, by Type, 2021 (%)
Global Pet Inactivated Vaccine Market Segment Percentages, by Application, 2021 (%)
Global Pet Inactivated Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Pet Inactivated Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pet Inactivated Vaccine revenues share in global market, 2021 (%)
Key companies Pet Inactivated Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Pet Inactivated Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Pet Inactivated Vaccine in global, including the following market information:
Global Pet Inactivated Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pet Inactivated Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Pet Inactivated Vaccine companies in 2021 (%)
The global Pet Inactivated Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Obtained by Heat Killing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pet Inactivated Vaccine include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska, Merck Animal Health, Merial (Sanofi) and Virbac and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pet Inactivated Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pet Inactivated Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pet Inactivated Vaccine Market Segment Percentages, by Type, 2021 (%)
- Obtained by Heat Killing
- Killed by Chemical Methods such as Formaldehyde
- Obtained by Radiation Killing
Global Pet Inactivated Vaccine Market Segment Percentages, by Application, 2021 (%)
- Dog
- Cat
- Dird
- Others
Global Pet Inactivated Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Pet Inactivated Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pet Inactivated Vaccine revenues share in global market, 2021 (%)
Key companies Pet Inactivated Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Pet Inactivated Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bayer Healthcare
- Vetoquinol S.A
- Boehringer Ingelheim
- Ceva
- Eli Lilly
- Heska
- Merck Animal Health
- Merial (Sanofi)
- Virbac
- Zoetis (Pfizer)
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Pet Inactivated Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pet Inactivated Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PET INACTIVATED VACCINE OVERALL MARKET SIZE
2.1 Global Pet Inactivated Vaccine Market Size: 2021 VS 2028
2.2 Global Pet Inactivated Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Pet Inactivated Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Pet Inactivated Vaccine Players in Global Market
3.2 Top Global Pet Inactivated Vaccine Companies Ranked by Revenue
3.3 Global Pet Inactivated Vaccine Revenue by Companies
3.4 Global Pet Inactivated Vaccine Sales by Companies
3.5 Global Pet Inactivated Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Pet Inactivated Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Pet Inactivated Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pet Inactivated Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Pet Inactivated Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Pet Inactivated Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Pet Inactivated Vaccine Market Size Markets, 2021 & 2028
4.1.2 Obtained by Heat Killing
4.1.3 Killed by Chemical Methods such as Formaldehyde
4.1.4 Obtained by Radiation Killing
4.2 By Type - Global Pet Inactivated Vaccine Revenue & Forecasts
4.2.1 By Type - Global Pet Inactivated Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Pet Inactivated Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Pet Inactivated Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Pet Inactivated Vaccine Sales & Forecasts
4.3.1 By Type - Global Pet Inactivated Vaccine Sales, 2017-2022
4.3.2 By Type - Global Pet Inactivated Vaccine Sales, 2023-2028
4.3.3 By Type - Global Pet Inactivated Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Pet Inactivated Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Pet Inactivated Vaccine Market Size, 2021 & 2028
5.1.2 Dog
5.1.3 Cat
5.1.4 Dird
5.1.5 Others
5.2 By Application - Global Pet Inactivated Vaccine Revenue & Forecasts
5.2.1 By Application - Global Pet Inactivated Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Pet Inactivated Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Pet Inactivated Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Pet Inactivated Vaccine Sales & Forecasts
5.3.1 By Application - Global Pet Inactivated Vaccine Sales, 2017-2022
5.3.2 By Application - Global Pet Inactivated Vaccine Sales, 2023-2028
5.3.3 By Application - Global Pet Inactivated Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Pet Inactivated Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Pet Inactivated Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Pet Inactivated Vaccine Revenue & Forecasts
6.2.1 By Region - Global Pet Inactivated Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Pet Inactivated Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Pet Inactivated Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Pet Inactivated Vaccine Sales & Forecasts
6.3.1 By Region - Global Pet Inactivated Vaccine Sales, 2017-2022
6.3.2 By Region - Global Pet Inactivated Vaccine Sales, 2023-2028
6.3.3 By Region - Global Pet Inactivated Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Pet Inactivated Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Pet Inactivated Vaccine Sales, 2017-2028
6.4.3 US Pet Inactivated Vaccine Market Size, 2017-2028
6.4.4 Canada Pet Inactivated Vaccine Market Size, 2017-2028
6.4.5 Mexico Pet Inactivated Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Pet Inactivated Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Pet Inactivated Vaccine Sales, 2017-2028
6.5.3 Germany Pet Inactivated Vaccine Market Size, 2017-2028
6.5.4 France Pet Inactivated Vaccine Market Size, 2017-2028
6.5.5 U.K. Pet Inactivated Vaccine Market Size, 2017-2028
6.5.6 Italy Pet Inactivated Vaccine Market Size, 2017-2028
6.5.7 Russia Pet Inactivated Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Pet Inactivated Vaccine Market Size, 2017-2028
6.5.9 Benelux Pet Inactivated Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Pet Inactivated Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Pet Inactivated Vaccine Sales, 2017-2028
6.6.3 China Pet Inactivated Vaccine Market Size, 2017-2028
6.6.4 Japan Pet Inactivated Vaccine Market Size, 2017-2028
6.6.5 South Korea Pet Inactivated Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Pet Inactivated Vaccine Market Size, 2017-2028
6.6.7 India Pet Inactivated Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Pet Inactivated Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Pet Inactivated Vaccine Sales, 2017-2028
6.7.3 Brazil Pet Inactivated Vaccine Market Size, 2017-2028
6.7.4 Argentina Pet Inactivated Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pet Inactivated Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Pet Inactivated Vaccine Sales, 2017-2028
6.8.3 Turkey Pet Inactivated Vaccine Market Size, 2017-2028
6.8.4 Israel Pet Inactivated Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Pet Inactivated Vaccine Market Size, 2017-2028
6.8.6 UAE Pet Inactivated Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Bayer Healthcare
7.1.1 Bayer Healthcare Corporate Summary
7.1.2 Bayer Healthcare Business Overview
7.1.3 Bayer Healthcare Pet Inactivated Vaccine Major Product Offerings
7.1.4 Bayer Healthcare Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Bayer Healthcare Key News
7.2 Vetoquinol S.A
7.2.1 Vetoquinol S.A Corporate Summary
7.2.2 Vetoquinol S.A Business Overview
7.2.3 Vetoquinol S.A Pet Inactivated Vaccine Major Product Offerings
7.2.4 Vetoquinol S.A Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Vetoquinol S.A Key News
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporate Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Pet Inactivated Vaccine Major Product Offerings
7.3.4 Boehringer Ingelheim Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Boehringer Ingelheim Key News
7.4 Ceva
7.4.1 Ceva Corporate Summary
7.4.2 Ceva Business Overview
7.4.3 Ceva Pet Inactivated Vaccine Major Product Offerings
7.4.4 Ceva Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Ceva Key News
7.5 Eli Lilly
7.5.1 Eli Lilly Corporate Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Pet Inactivated Vaccine Major Product Offerings
7.5.4 Eli Lilly Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Eli Lilly Key News
7.6 Heska
7.6.1 Heska Corporate Summary
7.6.2 Heska Business Overview
7.6.3 Heska Pet Inactivated Vaccine Major Product Offerings
7.6.4 Heska Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Heska Key News
7.7 Merck Animal Health
7.7.1 Merck Animal Health Corporate Summary
7.7.2 Merck Animal Health Business Overview
7.7.3 Merck Animal Health Pet Inactivated Vaccine Major Product Offerings
7.7.4 Merck Animal Health Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Merck Animal Health Key News
7.8 Merial (Sanofi)
7.8.1 Merial (Sanofi) Corporate Summary
7.8.2 Merial (Sanofi) Business Overview
7.8.3 Merial (Sanofi) Pet Inactivated Vaccine Major Product Offerings
7.8.4 Merial (Sanofi) Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Merial (Sanofi) Key News
7.9 Virbac
7.9.1 Virbac Corporate Summary
7.9.2 Virbac Business Overview
7.9.3 Virbac Pet Inactivated Vaccine Major Product Offerings
7.9.4 Virbac Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Virbac Key News
7.10 Zoetis (Pfizer)
7.10.1 Zoetis (Pfizer) Corporate Summary
7.10.2 Zoetis (Pfizer) Business Overview
7.10.3 Zoetis (Pfizer) Pet Inactivated Vaccine Major Product Offerings
7.10.4 Zoetis (Pfizer) Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Zoetis (Pfizer) Key News
8 GLOBAL PET INACTIVATED VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Pet Inactivated Vaccine Production Capacity, 2017-2028
8.2 Pet Inactivated Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Pet Inactivated Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PET INACTIVATED VACCINE SUPPLY CHAIN ANALYSIS
10.1 Pet Inactivated Vaccine Industry Value Chain
10.2 Pet Inactivated Vaccine Upstream Market
10.3 Pet Inactivated Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pet Inactivated Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Pet Inactivated Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pet Inactivated Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PET INACTIVATED VACCINE OVERALL MARKET SIZE
2.1 Global Pet Inactivated Vaccine Market Size: 2021 VS 2028
2.2 Global Pet Inactivated Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Pet Inactivated Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Pet Inactivated Vaccine Players in Global Market
3.2 Top Global Pet Inactivated Vaccine Companies Ranked by Revenue
3.3 Global Pet Inactivated Vaccine Revenue by Companies
3.4 Global Pet Inactivated Vaccine Sales by Companies
3.5 Global Pet Inactivated Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Pet Inactivated Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Pet Inactivated Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pet Inactivated Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Pet Inactivated Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Pet Inactivated Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Pet Inactivated Vaccine Market Size Markets, 2021 & 2028
4.1.2 Obtained by Heat Killing
4.1.3 Killed by Chemical Methods such as Formaldehyde
4.1.4 Obtained by Radiation Killing
4.2 By Type - Global Pet Inactivated Vaccine Revenue & Forecasts
4.2.1 By Type - Global Pet Inactivated Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Pet Inactivated Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Pet Inactivated Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Pet Inactivated Vaccine Sales & Forecasts
4.3.1 By Type - Global Pet Inactivated Vaccine Sales, 2017-2022
4.3.2 By Type - Global Pet Inactivated Vaccine Sales, 2023-2028
4.3.3 By Type - Global Pet Inactivated Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Pet Inactivated Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Pet Inactivated Vaccine Market Size, 2021 & 2028
5.1.2 Dog
5.1.3 Cat
5.1.4 Dird
5.1.5 Others
5.2 By Application - Global Pet Inactivated Vaccine Revenue & Forecasts
5.2.1 By Application - Global Pet Inactivated Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Pet Inactivated Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Pet Inactivated Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Pet Inactivated Vaccine Sales & Forecasts
5.3.1 By Application - Global Pet Inactivated Vaccine Sales, 2017-2022
5.3.2 By Application - Global Pet Inactivated Vaccine Sales, 2023-2028
5.3.3 By Application - Global Pet Inactivated Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Pet Inactivated Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Pet Inactivated Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Pet Inactivated Vaccine Revenue & Forecasts
6.2.1 By Region - Global Pet Inactivated Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Pet Inactivated Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Pet Inactivated Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Pet Inactivated Vaccine Sales & Forecasts
6.3.1 By Region - Global Pet Inactivated Vaccine Sales, 2017-2022
6.3.2 By Region - Global Pet Inactivated Vaccine Sales, 2023-2028
6.3.3 By Region - Global Pet Inactivated Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Pet Inactivated Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Pet Inactivated Vaccine Sales, 2017-2028
6.4.3 US Pet Inactivated Vaccine Market Size, 2017-2028
6.4.4 Canada Pet Inactivated Vaccine Market Size, 2017-2028
6.4.5 Mexico Pet Inactivated Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Pet Inactivated Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Pet Inactivated Vaccine Sales, 2017-2028
6.5.3 Germany Pet Inactivated Vaccine Market Size, 2017-2028
6.5.4 France Pet Inactivated Vaccine Market Size, 2017-2028
6.5.5 U.K. Pet Inactivated Vaccine Market Size, 2017-2028
6.5.6 Italy Pet Inactivated Vaccine Market Size, 2017-2028
6.5.7 Russia Pet Inactivated Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Pet Inactivated Vaccine Market Size, 2017-2028
6.5.9 Benelux Pet Inactivated Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Pet Inactivated Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Pet Inactivated Vaccine Sales, 2017-2028
6.6.3 China Pet Inactivated Vaccine Market Size, 2017-2028
6.6.4 Japan Pet Inactivated Vaccine Market Size, 2017-2028
6.6.5 South Korea Pet Inactivated Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Pet Inactivated Vaccine Market Size, 2017-2028
6.6.7 India Pet Inactivated Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Pet Inactivated Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Pet Inactivated Vaccine Sales, 2017-2028
6.7.3 Brazil Pet Inactivated Vaccine Market Size, 2017-2028
6.7.4 Argentina Pet Inactivated Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pet Inactivated Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Pet Inactivated Vaccine Sales, 2017-2028
6.8.3 Turkey Pet Inactivated Vaccine Market Size, 2017-2028
6.8.4 Israel Pet Inactivated Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Pet Inactivated Vaccine Market Size, 2017-2028
6.8.6 UAE Pet Inactivated Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Bayer Healthcare
7.1.1 Bayer Healthcare Corporate Summary
7.1.2 Bayer Healthcare Business Overview
7.1.3 Bayer Healthcare Pet Inactivated Vaccine Major Product Offerings
7.1.4 Bayer Healthcare Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Bayer Healthcare Key News
7.2 Vetoquinol S.A
7.2.1 Vetoquinol S.A Corporate Summary
7.2.2 Vetoquinol S.A Business Overview
7.2.3 Vetoquinol S.A Pet Inactivated Vaccine Major Product Offerings
7.2.4 Vetoquinol S.A Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Vetoquinol S.A Key News
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporate Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Pet Inactivated Vaccine Major Product Offerings
7.3.4 Boehringer Ingelheim Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Boehringer Ingelheim Key News
7.4 Ceva
7.4.1 Ceva Corporate Summary
7.4.2 Ceva Business Overview
7.4.3 Ceva Pet Inactivated Vaccine Major Product Offerings
7.4.4 Ceva Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Ceva Key News
7.5 Eli Lilly
7.5.1 Eli Lilly Corporate Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Pet Inactivated Vaccine Major Product Offerings
7.5.4 Eli Lilly Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Eli Lilly Key News
7.6 Heska
7.6.1 Heska Corporate Summary
7.6.2 Heska Business Overview
7.6.3 Heska Pet Inactivated Vaccine Major Product Offerings
7.6.4 Heska Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Heska Key News
7.7 Merck Animal Health
7.7.1 Merck Animal Health Corporate Summary
7.7.2 Merck Animal Health Business Overview
7.7.3 Merck Animal Health Pet Inactivated Vaccine Major Product Offerings
7.7.4 Merck Animal Health Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Merck Animal Health Key News
7.8 Merial (Sanofi)
7.8.1 Merial (Sanofi) Corporate Summary
7.8.2 Merial (Sanofi) Business Overview
7.8.3 Merial (Sanofi) Pet Inactivated Vaccine Major Product Offerings
7.8.4 Merial (Sanofi) Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Merial (Sanofi) Key News
7.9 Virbac
7.9.1 Virbac Corporate Summary
7.9.2 Virbac Business Overview
7.9.3 Virbac Pet Inactivated Vaccine Major Product Offerings
7.9.4 Virbac Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Virbac Key News
7.10 Zoetis (Pfizer)
7.10.1 Zoetis (Pfizer) Corporate Summary
7.10.2 Zoetis (Pfizer) Business Overview
7.10.3 Zoetis (Pfizer) Pet Inactivated Vaccine Major Product Offerings
7.10.4 Zoetis (Pfizer) Pet Inactivated Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Zoetis (Pfizer) Key News
8 GLOBAL PET INACTIVATED VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Pet Inactivated Vaccine Production Capacity, 2017-2028
8.2 Pet Inactivated Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Pet Inactivated Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PET INACTIVATED VACCINE SUPPLY CHAIN ANALYSIS
10.1 Pet Inactivated Vaccine Industry Value Chain
10.2 Pet Inactivated Vaccine Upstream Market
10.3 Pet Inactivated Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pet Inactivated Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Pet Inactivated Vaccine in Global Market
Table 2. Top Pet Inactivated Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Pet Inactivated Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Pet Inactivated Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Pet Inactivated Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Pet Inactivated Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Pet Inactivated Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Pet Inactivated Vaccine Product Type
Table 9. List of Global Tier 1 Pet Inactivated Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pet Inactivated Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pet Inactivated Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Pet Inactivated Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Pet Inactivated Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Pet Inactivated Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Pet Inactivated Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Pet Inactivated Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Pet Inactivated Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Pet Inactivated Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Pet Inactivated Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Pet Inactivated Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Pet Inactivated Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Pet Inactivated Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Pet Inactivated Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Pet Inactivated Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Pet Inactivated Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Pet Inactivated Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Pet Inactivated Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Pet Inactivated Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Pet Inactivated Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Pet Inactivated Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Pet Inactivated Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Pet Inactivated Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Pet Inactivated Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Pet Inactivated Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Pet Inactivated Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Pet Inactivated Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Pet Inactivated Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Pet Inactivated Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Pet Inactivated Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Pet Inactivated Vaccine Sales, (K Units), 2023-2028
Table 46. Bayer Healthcare Corporate Summary
Table 47. Bayer Healthcare Pet Inactivated Vaccine Product Offerings
Table 48. Bayer Healthcare Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Vetoquinol S.A Corporate Summary
Table 50. Vetoquinol S.A Pet Inactivated Vaccine Product Offerings
Table 51. Vetoquinol S.A Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Boehringer Ingelheim Corporate Summary
Table 53. Boehringer Ingelheim Pet Inactivated Vaccine Product Offerings
Table 54. Boehringer Ingelheim Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Ceva Corporate Summary
Table 56. Ceva Pet Inactivated Vaccine Product Offerings
Table 57. Ceva Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Eli Lilly Corporate Summary
Table 59. Eli Lilly Pet Inactivated Vaccine Product Offerings
Table 60. Eli Lilly Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Heska Corporate Summary
Table 62. Heska Pet Inactivated Vaccine Product Offerings
Table 63. Heska Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Merck Animal Health Corporate Summary
Table 65. Merck Animal Health Pet Inactivated Vaccine Product Offerings
Table 66. Merck Animal Health Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Merial (Sanofi) Corporate Summary
Table 68. Merial (Sanofi) Pet Inactivated Vaccine Product Offerings
Table 69. Merial (Sanofi) Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Virbac Corporate Summary
Table 71. Virbac Pet Inactivated Vaccine Product Offerings
Table 72. Virbac Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Zoetis (Pfizer) Corporate Summary
Table 74. Zoetis (Pfizer) Pet Inactivated Vaccine Product Offerings
Table 75. Zoetis (Pfizer) Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Pet Inactivated Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Pet Inactivated Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Pet Inactivated Vaccine Production by Region, 2017-2022 (K Units)
Table 79. Global Pet Inactivated Vaccine Production by Region, 2023-2028 (K Units)
Table 80. Pet Inactivated Vaccine Market Opportunities & Trends in Global Market
Table 81. Pet Inactivated Vaccine Market Drivers in Global Market
Table 82. Pet Inactivated Vaccine Market Restraints in Global Market
Table 83. Pet Inactivated Vaccine Raw Materials
Table 84. Pet Inactivated Vaccine Raw Materials Suppliers in Global Market
Table 85. Typical Pet Inactivated Vaccine Downstream
Table 86. Pet Inactivated Vaccine Downstream Clients in Global Market
Table 87. Pet Inactivated Vaccine Distributors and Sales Agents in Global Market
Table 1. Key Players of Pet Inactivated Vaccine in Global Market
Table 2. Top Pet Inactivated Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Pet Inactivated Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Pet Inactivated Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Pet Inactivated Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Pet Inactivated Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Pet Inactivated Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Pet Inactivated Vaccine Product Type
Table 9. List of Global Tier 1 Pet Inactivated Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pet Inactivated Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pet Inactivated Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Pet Inactivated Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Pet Inactivated Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Pet Inactivated Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Pet Inactivated Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Pet Inactivated Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Pet Inactivated Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Pet Inactivated Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Pet Inactivated Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Pet Inactivated Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Pet Inactivated Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Pet Inactivated Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Pet Inactivated Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Pet Inactivated Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Pet Inactivated Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Pet Inactivated Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Pet Inactivated Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Pet Inactivated Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Pet Inactivated Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Pet Inactivated Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Pet Inactivated Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Pet Inactivated Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Pet Inactivated Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Pet Inactivated Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Pet Inactivated Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Pet Inactivated Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Pet Inactivated Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Pet Inactivated Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Pet Inactivated Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Pet Inactivated Vaccine Sales, (K Units), 2023-2028
Table 46. Bayer Healthcare Corporate Summary
Table 47. Bayer Healthcare Pet Inactivated Vaccine Product Offerings
Table 48. Bayer Healthcare Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Vetoquinol S.A Corporate Summary
Table 50. Vetoquinol S.A Pet Inactivated Vaccine Product Offerings
Table 51. Vetoquinol S.A Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Boehringer Ingelheim Corporate Summary
Table 53. Boehringer Ingelheim Pet Inactivated Vaccine Product Offerings
Table 54. Boehringer Ingelheim Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Ceva Corporate Summary
Table 56. Ceva Pet Inactivated Vaccine Product Offerings
Table 57. Ceva Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Eli Lilly Corporate Summary
Table 59. Eli Lilly Pet Inactivated Vaccine Product Offerings
Table 60. Eli Lilly Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Heska Corporate Summary
Table 62. Heska Pet Inactivated Vaccine Product Offerings
Table 63. Heska Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Merck Animal Health Corporate Summary
Table 65. Merck Animal Health Pet Inactivated Vaccine Product Offerings
Table 66. Merck Animal Health Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Merial (Sanofi) Corporate Summary
Table 68. Merial (Sanofi) Pet Inactivated Vaccine Product Offerings
Table 69. Merial (Sanofi) Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Virbac Corporate Summary
Table 71. Virbac Pet Inactivated Vaccine Product Offerings
Table 72. Virbac Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Zoetis (Pfizer) Corporate Summary
Table 74. Zoetis (Pfizer) Pet Inactivated Vaccine Product Offerings
Table 75. Zoetis (Pfizer) Pet Inactivated Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Pet Inactivated Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Pet Inactivated Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Pet Inactivated Vaccine Production by Region, 2017-2022 (K Units)
Table 79. Global Pet Inactivated Vaccine Production by Region, 2023-2028 (K Units)
Table 80. Pet Inactivated Vaccine Market Opportunities & Trends in Global Market
Table 81. Pet Inactivated Vaccine Market Drivers in Global Market
Table 82. Pet Inactivated Vaccine Market Restraints in Global Market
Table 83. Pet Inactivated Vaccine Raw Materials
Table 84. Pet Inactivated Vaccine Raw Materials Suppliers in Global Market
Table 85. Typical Pet Inactivated Vaccine Downstream
Table 86. Pet Inactivated Vaccine Downstream Clients in Global Market
Table 87. Pet Inactivated Vaccine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Pet Inactivated Vaccine Segment by Type
Figure 2. Pet Inactivated Vaccine Segment by Application
Figure 3. Global Pet Inactivated Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pet Inactivated Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pet Inactivated Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Pet Inactivated Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pet Inactivated Vaccine Revenue in 2021
Figure 9. By Type - Global Pet Inactivated Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Pet Inactivated Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Pet Inactivated Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Pet Inactivated Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Pet Inactivated Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Pet Inactivated Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Pet Inactivated Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Pet Inactivated Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Pet Inactivated Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Pet Inactivated Vaccine Sales Market Share, 2017-2028
Figure 19. US Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Pet Inactivated Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Pet Inactivated Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Pet Inactivated Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Pet Inactivated Vaccine Sales Market Share, 2017-2028
Figure 33. China Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Pet Inactivated Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Pet Inactivated Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Pet Inactivated Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Pet Inactivated Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Pet Inactivated Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Pet Inactivated Vaccine by Region, 2021 VS 2028
Figure 50. Pet Inactivated Vaccine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Pet Inactivated Vaccine Segment by Type
Figure 2. Pet Inactivated Vaccine Segment by Application
Figure 3. Global Pet Inactivated Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pet Inactivated Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pet Inactivated Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Pet Inactivated Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pet Inactivated Vaccine Revenue in 2021
Figure 9. By Type - Global Pet Inactivated Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Pet Inactivated Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Pet Inactivated Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Pet Inactivated Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Pet Inactivated Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Pet Inactivated Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Pet Inactivated Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Pet Inactivated Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Pet Inactivated Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Pet Inactivated Vaccine Sales Market Share, 2017-2028
Figure 19. US Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Pet Inactivated Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Pet Inactivated Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Pet Inactivated Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Pet Inactivated Vaccine Sales Market Share, 2017-2028
Figure 33. China Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Pet Inactivated Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Pet Inactivated Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Pet Inactivated Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Pet Inactivated Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Pet Inactivated Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Pet Inactivated Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Pet Inactivated Vaccine by Region, 2021 VS 2028
Figure 50. Pet Inactivated Vaccine Industry Value Chain
Figure 51. Marketing Channels
